Brief: RhoVac: Positive Results In Phase I/II Clinical Study

Chosa Oncology AB

01/08/2018 13:06

Aug 1 (Reuters) - RHOVAC AB  RHOVAC.TE :
    * RHOVAC'S REPORTS POSITIVE RESULTS IN THE COMPANY'S PHASE
I/II
CLINICAL STUDY
    * SAYS POSITIVE TOP-LINE RESULTS ON SAFETY AND ON IMMUNE
ACTIVATION IN PHASE I/II CLINICAL TRIAL RHOVAC-001 IN PROSTATE
CANCER PATIENTS
    * REGIMEN WAS WELL TOLERATED AND THERE WERE NO TREATMENT
RELATED
GRADE 3, 4 OR 5 REACTIONS ACCORDING TO CTCAE
    * PRIMARY END-POINT OF STUDY WAS THEREFORE ACHIEVED.

Source text for Eikon:  ID:nWkr9fKn8m 
Further company coverage:  RHOVAC.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))